angiogenesis modulators (P&U)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameangiogenesis modulators (P&U)
Drug Alias Nameoxindole derivatives (P&U)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-tyrosine kinases inhibitors
TargetsProtein-tyrosine kinases
Therapy Area/IndicationsAngiogenesis disorderAlzheimer DiseaseNeoplasm Metastasis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmacia & Upjohn Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmacia & Upjohn Spa
Active IndicationsN/A
Inactive IndicationsAngiogenesis disorderAlzheimer DiseaseNeoplasm Metastasis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A